FDA approves second GPCR-targeted antibody
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Drug Discovery"
DOI: 10.1038/nrd.2018.153
Abstract: asthma and eczema, and plays a role in controlling the trafficking of immune cells. The surface receptor has stymied the efforts of small-molecule drug developers, but scientists at Kyowa Hakko Kirin found that their mogamulizumab… read more here.
Keywords: second gpcr; fda approves; approves second; gpcr targeted ... See more keywords